Brief: Galera Announces Final Results From Pancreatic Cancer Trial Showing Improvements On All Efficacy Parameters
08/09/2021 12:08
Sept 8 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA ANNOUNCES FINAL RESULTS FROM PANCREATIC CANCER
TRIAL
SHOWING IMPROVEMENTS ON ALL EFFICACY PARAMETERS
* GALERA THERAPEUTICS INC - HAZARD RATIOS BETTER THAN 0.5 ON
ALL
SURVIVAL AND TUMOR OUTCOME ENDPOINTS
* GALERA THERAPEUTICS INC - COMBINATION WITH SBRT WAS WELL
TOLERATED IN ACTIVE AND PLACEBO ARMS
Source text for Eikon: ID:nGNXHPtxH
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement